Growth differentiation factor 11 signaling controls retinoic acid activity for axial vertebral development

Developmental Biology

Volumn 347, Issue 1, 2010, Pages 195-203

  Lee, Young Jae ^a,b   McPherron, Alexandra ^c   Choe, Susan ^a   Sakai, Yasuo ^d   Chandraratna, Roshantha A ^e   Lee, Se Jin ^c   Oh, S Paul ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Gachon University   (South Korea)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FUJITA HEALTH UNIVERSITY   (Japan)

^e NuRx Pharmaceuticals Inc   (United States)

Author keywords

ACVR2; CYP26A1; GDF11; RAR inhibitor; Retinoic acid; Vertebral patterning

Indexed keywords

4 [2 [5,6 DIHYDRO 5,5 DIMETHYL 8 (4 METHYLPHENYL) 2 NAPHTHYL]ETHYNYL]BENZOIC ACID; CYTOCHROME P450 26A1; GROWTH DIFFERENTIATION FACTOR 1; MUTANT PROTEIN; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; FEMALE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOMITE; SPINE; VERTEBRA;

MUS;

EID: 77957316867     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2010.08.022     Document Type: Article

References (47)

1. Abu-Abed S., Dolle P., Metzger D., Beckett B., Chambon P., Petkovich M. The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. Genes Dev. 2001, 15:226-240.
2. Abu-Abed S., Dolle P., Metzger D., Wood C., MacLean G., Chambon P., Petkovich M. Developing with lethal RA levels: genetic ablation of Rarg can restore the viability of mice lacking Cyp26a1. Development 2003, 130:1449-1459.
3. Agarwal C., Chandraratna R.A.S., Johnson A.T., Rorke E.A., Eckert R.L. AGN193109 is a highly effective agonist of retinoid action in human ectocervical epithelial cells. J. Biol. Chem. 1996, 271:12209-12212.
4. Akasaka T., van Lohuizen M., van der Lugt N., Mizutani-Koseki Y., Kanno M., Taniguchi M., Vidal M., Alkema M., Berns A., Koseki H. Mice doubly deficient for the Polycomb Group genes Mel18 and Bmi1 reveal synergy and requirement for maintenance but not initiation of Hox gene expression. Development 2001, 128:1587-1597.
5. Allan D., Houle M., Bouchard N., Meyer B.I., Gruss P., Lohnes D. RARgamma and Cdx1 interactions in vertebral patterning. Dev. Biol. 2001, 240:46-60.
6. Andersson O., Reissmann E., Ibanez C.F. Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis. EMBO Rep. 2006, 7:831-837.
7. Baker R.E., Schnell S., Maini P.K. A clock and wavefront mechanism for somite formation. Dev. Biol. 2006, 293:116-126.
8. Carapuco M., Novoa A., Bobola N., Mallo M. Hox genes specify vertebral types in the presomitic mesoderm. Genes Dev. 2005, 19:2116-2121.
9. Core N., Bel S., Gaunt S.J., Aurrand-Lions M., Pearce J., Fisher A., Djabali M. Altered cellular proliferation and mesoderm patterning in Polycomb-M33-deficient mice. Development 1997, 124:721-729.
10. Dichmann D.S., Yassin H., Serup P. Analysis of pancreatic endocrine development in GDF11-deficient mice. Dev. Dyn. 2006, 235:3016-3025.
11. Esquela A.F., Lee S.J. Regulation of metanephric kidney development by growth/differentiation factor 11. Dev. Biol. 2003, 257:356-370.
12. Essalmani R., Zaid A., Marcinkiewicz J., Chamberland A., Pasquato A., Seidah N.G., Prat A. In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate. Proc. Natl. Acad. Sci. 2008, 105:5750-5755.
13. Gregg D. Retinoic acid regulation of the somitogenesis clock. Birth Defects Res. C: Embryo Today: Reviews 2007, 81:84-92.
14. Johnson A.T., Klein E.S., Gillett S.J., Wang L.M., Song T.K., Pino M.E., Chandraratna R.A.S. Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J. Med. Chem. 1995, 38:4764-4767.
15. Joo J.H., Lee Y.J., Munguba G.C., Park S., Taxter T.J., Elsagga M.Y., Jackson M.R., Oh S.P., Sugrue S.P. Role of Pinin in neural crest, dorsal dermis, and axial skeleton development and its involvement in the regulation of Tcf/Lef activity in mice. Dev. Dyn. 2007, 236:2147-2158.
16. Kessel M. Respecification of vertebral identities by retinoic acid. Development 1992, 115:487-501.
17. Kessel M., Gruss P. Homeotic transformations of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid. Cell 1991, 67:89-104.
18. Lee Y.J., Hong K.H., Yun J., Oh S.P. Generation of activin receptor type IIB isoform-specific hypomorphic alleles. Genesis 2006, 44:487-494.
19. Mahmood R., Bresnick J., Hornbruch A., Mahony C., Morton N., Colquhoun K., Martin P., Lumsden A., Dickson C., Mason I. A role for FGF-8 in the initiation and maintenance of vertebrate limb bud outgrowth. Curr. Biol. 1995, 5:797-806.
20. Mallo M., Vinagre T., Carapuco M. The road to the vertebral formula. Int. J. Dev. Biol. 2009, 53:1469-1481.
21. Mark M., Ghyselinck N.B., Chambon P. Function of retinoic acid receptors during embryonic development. Nucl. Recept. Signal. 2009, 7:e002.
22. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 1998, 67:753-791.
23. McIntyre D.C., Rakshit S., Yallowitz A.R., Loken L., Jeannotte L., Capecchi M.R., Wellik D.M. Hox patterning of the vertebrate rib cage. Development 2007, 134:2981-2989.
24. McPherron A.C., Lawler A.M., Lee S.J. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat. Genet. 1999, 22:260-264.
25. McPherron A.C., Huynh T.V., Lee S.J. Redundancy of myostatin and growth/differentiation factor 11 function. BMC Dev. Biol. 2009, 9:24.
26. Nakashima M., Toyono T., Akamine A., Joyner A. Expression of growth/differentiation factor 11, a new member of the BMP/TGF[beta] superfamily during mouse embryogenesis. Mech. Dev. 1999, 80:185-189.
27. Niederreither K., McCaffery P., Drager U.C., Chambon P., Dolle P. Restricted expression and retinoic acid-induced downregulation of the retinaldehyde dehydrogenase type 2 (RALDH-2) gene during mouse development. Mech. Dev. 1997, 62:67-78.
28. Nowicki J.L., Burke A.C. Hox genes and morphological identity: axial versus lateral patterning in the vertebrate mesoderm. Development 2000, 127:4265-4275.
29. Oh S.P., Li E. The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev. 1997, 11:1812-1826.
30. Oh S.P., Yeo C.Y., Lee Y., Schrewe H., Whitman M., Li E. Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. Genes Dev. 2002, 16:2749-2754.
31. Park S., Lee Y.J., Lee H.J., Seki T., Hong K.H., Park J., Beppu H., Lim I.K., Yoon J.W., Li E., Kim S.J., Oh S.P. B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling. Mol. Cell. Biol. 2004, 24:10256-10262.
32. Pearlmann T. Retinoid metabolism: a balancing act. Nat. Genet. 2002, 31:7-8.
33. Rossant J., Zirngibl R., Cado D., Shago M., Giguere V. Expression of a retinoic acid response element-hsplacZ transgene defines specific domains of transcriptional activity during mouse embryogenesis. Genes Dev. 1991, 5:1333-1344.
34. Saga Y., Takeda H. The making of the somite: molecular events in vertebrate segmentation. Nat. Rev. Genet. 2001, 2:835-845.
35. Saga Y., Hata N., Koseki H., Taketo M.M. Mesp2: a novel mouse gene expressed in the presegmented mesoderm and essential for segmentation initiation. Genes Dev. 1997, 11:1827-1839.
36. Sakai Y., Meno C., Fujii H., Nishino J., Shiratori H., Saijoh Y., Rossant J., Hamada H. The retinoic acid-inactivating enzyme CYP26 is essential for establishing an uneven distribution of retinoic acid along the anterio-posterior axis within the mouse embryo. Genes Dev. 2001, 15:213-225.
37. Seidah N.G., Mayer G., Zaid A., Rousselet E., Nassoury N., Poirier S., Essalmani R., Prat A. The activation and physiological functions of the proprotein convertases. Int. J. Biochem. Cell Biol. 2008, 40:1111-1125.
38. Song J., Oh S.P., Schrewe H., Nomura M., Lei H., Okano M., Gridley T., Li E. The type II activin receptors are essential for egg cylinder growth, gastrulation, and rostral head development in mice. Dev. Biol. 1999, 213:157-169.
39. Stoppie P., Borgers M., Borghgraef P., Dillen L., Goossens J., Sanz G., Szel H., Van Hove C., Van Nyen G., Nobels G., Vanden Bossche H., Venet M., Willemsens G., Van Wauwe J. R115866 inhibits all-trans-retinoic acid metabolism and exerts retinoidal effects in rodents. J. Pharmacol. Exp. Ther. 2000, 293:304-312.
40. Szumska D., Pieles G., Essalmani R., Bilski M., Mesnard D., Kaur K., Franklyn A., El Omari K., Jefferis J., Bentham J., Taylor J.M., Schneider J.E., Arnold S.J., Johnson P., Tymowska-Lalanne Z., Stammers D., Clarke K., Neubauer S., Morris A., Brown S.D., Shaw-Smith C., Cama A., Capra V., Ragoussis J., Constam D., Seidah N.G., Prat A., Bhattacharya S. VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5. Genes Dev. 2008, 22:1465-1477.
41. Takahashi Y., Koizumi K., Takagi A., Kitajima S., Inoue T., Koseki H., Saga Y. Mesp2 initiates somite segmentation through the Notch signalling pathway. Nat. Genet. 2000, 25:390-396.
42. van den Akker E., Forlani S., Chawengsaksophak K., de Graaff W., Beck F., Meyer B.I., Deschamps J. Cdx1 and Cdx2 have overlapping functions in anteroposterior patterning and posterior axis elongation. Development 2002, 129:2181-2193.
43. Wellik D.M. Hox patterning of the vertebrate axial skeleton. Dev. Dyn. 2007, 236:2454-2463.
44. Wellik D.M., Capecchi M.R. Hox10 and Hox11 genes are required to globally pattern the mammalian skeleton. Science 2003, 301:363-367.
45. White J.A., Guo Y.D., Baetz K., Beckett-Jones B., Bonasoro J., Hsu K.E., Dilworth F.J., Jones G., Petkovich M. Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase. J. Biol. Chem. 1996, 271:29922-29927.
46. Wilkinson D.G. In situ hybridization: a practical approach 1992, Oxford University Press, London, United Kingdom.
47. Yang X., Letterio J.J., Lechleider R.J., Chen L., Hayman R., Gu H., Roberts A.B., Deng C. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J. 1999, 18:1280-1291.